SBC Medical Group Holdings Incorporated carries a market capitalization of 546.12M, placing it among publicly traded companies globally. Its enterprise value stands at 195.63M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 546.12M |
| Enterprise Value | 195.63M |
SBC Medical Group Holdings Incorporated currently has 102.58M shares outstanding.
| Shares Outstanding | 102.58M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
SBC Medical Group Holdings Incorporated trades at a trailing price-to-earnings ratio of 6.45. The price-to-sales ratio is 1.80, and the price-to-book ratio stands at 1.20.
| PE Ratio | 6.45 |
| PS Ratio | 1.80 |
| PB Ratio | 1.20 |
| P/TBV Ratio | 1.56 |
| P/FCF Ratio | 4.84 |
| P/OCF Ratio | 5.03 |
On an enterprise value basis, SBC Medical Group Holdings Incorporated trades at an EV/EBITDA multiple of 2.85 and an EV/FCF ratio of 2.99. The EV/Sales ratio of 1.12 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 2.99 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.12 |
| EV / EBITDA | 2.85 |
| EV / EBIT | 2.99 |
| EV / FCF | 2.99 |
SBC Medical Group Holdings Incorporated maintains a current ratio of 3.31, meaning it holds 3.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 17.23, indicating elevated leverage, while an interest coverage ratio of 197.13 demonstrates strong ability to service its debt obligations.
| Current Ratio | 3.31 |
| Quick Ratio | 3.18 |
| Debt / Equity | 17.23 |
| Debt / EBITDA | 0.70 |
| Interest Coverage | 197.13 |
SBC Medical Group Holdings Incorporated posts a return on equity of 19.29 and a return on invested capital of 13.85.
| Return on Equity (ROE) | 19.29 |
| Return on Assets (ROA) | 13.58 |
| Return on Invested Capital (ROIC) | 13.85 |
| Return on Capital Employed (ROCE) | 16.55 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 21.05 |
Over the trailing twelve months, SBC Medical Group Holdings Incorporated has paid 25.31M in income taxes, reflecting an effective tax rate of 33.53.
| Income Tax | 25.31M |
| Effective Tax Rate | 33.53 |
SBC Medical Group Holdings Incorporated's stock has gained approximately 27.95181% over the past 52 weeks. The 50-day moving average sits at 4.51, while the 200-day moving average is 3.87.
| Beta (5Y) | N/A |
| 52-Week Price Change | 27.95181% |
| 50-Day Moving Average | 4.51 |
| 200-Day Moving Average | 3.87 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, SBC Medical Group Holdings Incorporated generated 175.17M in revenue and converted that into 49.03M in net income, yielding earnings per share of 0.48. EBITDA reached 68.63M, while operating income came in at 65.41M.
| Revenue | 175.17M |
| Gross Profit | 125.86M |
| Operating Income | 65.41M |
| Pretax Income | 75.49M |
| Net Income | 49.03M |
| EBITDA | 68.63M |
| EBIT | 65.41M |
| Earnings Per Share (EPS) | 0.48 |
SBC Medical Group Holdings Incorporated holds 184.62M in cash and equivalents against 48.23M in total debt, resulting in a net debt position of -146.56M. Total book value stands at 263.84M, with working capital of 180.93M providing operational flexibility.
| Cash & Cash Equivalents | 184.62M |
| Total Debt | 48.23M |
| Net Debt | -146.56M |
| Equity (Book Value) | 263.84M |
| Book Value Per Share | 2.57 |
| Working Capital | 180.93M |
SBC Medical Group Holdings Incorporated produced 62.82M in operating cash flow over the past twelve months. After subtracting -2.45M in capital expenditures, free cash flow totaled 60.37M - equivalent to 0.59 per share.
| Operating Cash Flow | 62.82M |
| Capital Expenditures | -2.45M |
| Free Cash Flow | 60.37M |
| FCF Per Share | 0.59 |
SBC Medical Group Holdings Incorporated operates with a gross margin of 71.85, reflecting its pricing power and cost economics. The operating margin of 37.34 and net profit margin of 27.99 provide insight into operational efficiency.
| Gross Margin | 71.85 |
| Operating Margin | 37.34 |
| Pretax Margin | 43.09 |
| Profit Margin | 27.99 |
| EBITDA Margin | 39.18 |
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -8.73 |
| FCF Yield | 20.66 |
SBC Medical Group Holdings Incorporated posts an Altman Z-Score of 4.32, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 4.32 |